October 20, 2016 6:57 PM ET


Company Overview of Copernicus Therapeutics, Inc.

Executive Profile

Pamela B. Davis M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Ms. Pamela B. Davis, M.D., Ph.D. serves as Dean and Vice President for Medical Affairs of Case Western Reserve University School of Medicine. Ms. Davis co-founded Copernicus Therapeutics, Inc., 1995. Ms. Davis serves as a Director of BioEnterprise Corporation.

Corporate Headquarters

11000 Cedar Avenue
Cleveland, Ohio 44106-3052

United States

Phone: 216-231-0227
Fax: 216-231-9477

Board Members Memberships



There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Copernicus Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.